Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Heise

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Anatomy and Embryology|October 21, 2005
Cell survival patterns in the pedunculopontine tegmental nucleus of methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys and 6OHDA-lesioned rats: evidence for differences to idiopathic Parkinson disease patients?Claire E Heise, Zui Chih Teo, Bradley A Wallace, et al.
The Journal of Biological Chemistry|December 29, 2006
NMR structural characterization of a minimal peptide antagonist bound to the extracellular domain of the corticotropin-releasing factor1 receptorMichael F Mesleh, William A Shirley, Christopher E Heise, et al.
Archiv Fur Geschwulstforschung|January 1, 1973
[The biological individuality of human tumours]S Tanneberger, K Rieche, G Butschak, et al.
The Journal of Biological Chemistry|October 24, 2000
Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is Edg-receptor independentS B Hooks, W L Santos, D S Im, et al.
Brain : a Journal of Neurology|June 23, 2007
Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeysBradley A Wallace, Keyoumars Ashkan, Claire E Heise, et al.
Archiv Fur Geschwulstforschung|January 1, 1981
High risk breast cancer: long-term surgical adjuvant therapy based on predictive tests - preliminary reportU Peek, S Tanneberger, E Heise, et al.
Molecular Pharmacology|March 23, 2000
Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostateD S Im, C E Heise, M A Harding, et al.
Molecular Pharmacology|November 28, 2001
Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors: discovery of a LPA1/LPA3 receptor antagonistC E Heise, W L Santos, A M Schreihofer, et al.
Biochemical Pharmacology|August 26, 2006
Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure-activity relationships and insurmountable antagonismSusan K Sullivan, Sam R J Hoare, Beth A Fleck, et al.
Plos One|January 19, 2012
A whole cell assay to measure caspase-6 activity by detecting cleavage of lamin A/CRobert Mintzer, Sreemathy Ramaswamy, Kinjalkumar Shah, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Anatomy and Embryology|October 21, 2005
Cell survival patterns in the pedunculopontine tegmental nucleus of methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys and 6OHDA-lesioned rats: evidence for differences to idiopathic Parkinson disease patients?Claire E Heise, Zui Chih Teo, Bradley A Wallace, et al.
The Journal of Biological Chemistry|December 29, 2006
NMR structural characterization of a minimal peptide antagonist bound to the extracellular domain of the corticotropin-releasing factor1 receptorMichael F Mesleh, William A Shirley, Christopher E Heise, et al.
Archiv Fur Geschwulstforschung|January 1, 1973
[The biological individuality of human tumours]S Tanneberger, K Rieche, G Butschak, et al.
The Journal of Biological Chemistry|October 24, 2000
Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is Edg-receptor independentS B Hooks, W L Santos, D S Im, et al.
Brain : a Journal of Neurology|June 23, 2007
Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeysBradley A Wallace, Keyoumars Ashkan, Claire E Heise, et al.
Archiv Fur Geschwulstforschung|January 1, 1981
High risk breast cancer: long-term surgical adjuvant therapy based on predictive tests - preliminary reportU Peek, S Tanneberger, E Heise, et al.
Molecular Pharmacology|March 23, 2000
Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostateD S Im, C E Heise, M A Harding, et al.
Molecular Pharmacology|November 28, 2001
Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors: discovery of a LPA1/LPA3 receptor antagonistC E Heise, W L Santos, A M Schreihofer, et al.
Biochemical Pharmacology|August 26, 2006
Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure-activity relationships and insurmountable antagonismSusan K Sullivan, Sam R J Hoare, Beth A Fleck, et al.
Plos One|January 19, 2012
A whole cell assay to measure caspase-6 activity by detecting cleavage of lamin A/CRobert Mintzer, Sreemathy Ramaswamy, Kinjalkumar Shah, et al.
Pageof 8